1. Home
  2. COEP vs DMN Comparison

COEP vs DMN Comparison

Compare COEP & DMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • DMN
  • Stock Information
  • Founded
  • COEP 2017
  • DMN 2020
  • Country
  • COEP United States
  • DMN Canada
  • Employees
  • COEP 7
  • DMN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • DMN
  • Sector
  • COEP Health Care
  • DMN
  • Exchange
  • COEP Nasdaq
  • DMN NYSE
  • Market Cap
  • COEP 22.3M
  • DMN 19.4M
  • IPO Year
  • COEP N/A
  • DMN N/A
  • Fundamental
  • Price
  • COEP $9.27
  • DMN $0.73
  • Analyst Decision
  • COEP
  • DMN
  • Analyst Count
  • COEP 0
  • DMN 0
  • Target Price
  • COEP N/A
  • DMN N/A
  • AVG Volume (30 Days)
  • COEP 1.0M
  • DMN 442.1K
  • Earning Date
  • COEP 11-13-2024
  • DMN 02-15-2025
  • Dividend Yield
  • COEP N/A
  • DMN N/A
  • EPS Growth
  • COEP N/A
  • DMN N/A
  • EPS
  • COEP N/A
  • DMN N/A
  • Revenue
  • COEP N/A
  • DMN N/A
  • Revenue This Year
  • COEP N/A
  • DMN N/A
  • Revenue Next Year
  • COEP N/A
  • DMN N/A
  • P/E Ratio
  • COEP N/A
  • DMN N/A
  • Revenue Growth
  • COEP N/A
  • DMN N/A
  • 52 Week Low
  • COEP $2.31
  • DMN $0.51
  • 52 Week High
  • COEP $13.58
  • DMN $4.95
  • Technical
  • Relative Strength Index (RSI)
  • COEP 75.88
  • DMN N/A
  • Support Level
  • COEP $6.22
  • DMN N/A
  • Resistance Level
  • COEP $10.00
  • DMN N/A
  • Average True Range (ATR)
  • COEP 1.79
  • DMN 0.00
  • MACD
  • COEP 0.43
  • DMN 0.00
  • Stochastic Oscillator
  • COEP 90.51
  • DMN 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About DMN DAMON INC

Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.

Share on Social Networks: